Jobs / United States / Astrazeneca Pharmaceuticals Lp
Associate Director, Oncology Outcomes Research
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
At AstraZeneca, we pride ourselves on crafting a collaborative culture that champions knowledge-sharing, ambitious thinking and innovation – ultimately providing employees with the opportunity to work across teams, functions and even the globe. Do you have expertise in, and curiosity for leading Medical Affairs teams in Oncology ? Apply your experience to changing the way cancer is treated at AstraZeneca , a company that follows the science and turns ideas into life changing medicines. Help to advance our incredible pipeline by applying expertise and accelerating our pathway to finding a cure. A dedicated Oncology Business Unit (OBU), this is the place to build a best-in-class career. AstraZeneca’s vision in Oncology is to help patients by redefining the cancer-treatment paradigm with the bold ambition to eliminate cancer as a cause of death. We are proud to work on ground-breaking science with one of the broadest and deepest Oncology pipelines in the business. The Associate Director, Oncology Outcomes Research is an individual contributor role and will be a key member of an Asset team that is collectively responsible for delivering strategic plans and executing projects. The Associate Director, Oncology Outcomes Research reports to the Asset Lead and will be responsible for supporting the development of strategy and leading the execution of health outcomes and real-world strategies and studies on a global and US market level. This role is also responsible for working with key internal stakeholders in the design, execution and communication of studies. This position requires an individual with scientific knowledge of HEOR and its application throughout development process, business acumen, and interpersonal skills. What You'll Do: • Responsible for the execution of the Asset strategy including real world evidence, and other activities to assess, quantify and communicate the value proposition for the asset. • Responsible for supporting the development and leading the execution of asset specific Global and US Regional health outcomes strategy. • Responsible for strategically communicating and influencing a diverse group of internal and external collaborators in GMA, OBU and ORD. • Supports the asset lead in key internal review and governance meetings to ensure the scientific difficulty of AZ sponsored research including ERT. • Present research findings at scientific congresses and participate in the development and writing of manuscripts for publication in peer-reviewed journals • Translate output from research into tools and resources for field teams • Manage relationships and budgets with vendors to ensure timely completion of high quality, projects • Maintain in-depth knowledge of the disease state, market & customer dynamics, the competitive landscape, and reimbursement issues Minimum Qualifications: • Minimum 3 years’ experience, preferably in the pharmaceutical industry, graduate degree strongly preferred (PhD, MS, MPH) in health economics, epidemiology, outcomes research and/or related disciplines. • Understanding and knowledge and application of epidemiological/health outcomes methodology within pharmaceutical industry at an international level. • In-depth expertise with research methods for real world research, HEOR projects including pharmacoepidemiologic models. • Knowledge of the Global and US healthcare systems and their changing needs for health economic and payer analytic information. • Scientific expertise in oncology with knowledge of different data sources • Demonstrated expertise in analytical, judgment and problem-solving skills. Preferred Qualifications: • Advanced Scientific degree • Developed conceptual and integrative thinking with capability to access interna